Virbac (Virbac) Price-to-Tangible-Book

: 4.65 (As of Today)

View and export this data going back to . Start your Free Trial

As of today (2024-04-19), Virbac's share price is $354.75. Virbac's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $76.32. Hence, Virbac's Price to Tangible Book Ratio of today is 4.65.

The historical rank and industry rank for Virbac's Price-to-Tangible-Book or its related term are showing as below:

VRBCF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.57 Med: 6.17 Max: 44.88
Current: 5.18

During the past 13 years, Virbac's highest Price to Tangible Book Ratio was 44.88. The lowest was 3.57. And the median was 6.17.

VRBCF's Price-to-Tangible-Book is ranked worse than
80.39% of 872 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs VRBCF: 5.18

A closely related ratio is called PB Ratio. As of today, Virbac's share price is $354.75. Virbac's Book Value per Sharefor the quarter that ended in Jun. 2023 was $115.30. Hence, Virbac's P/B Ratio of today is 3.08.

Virbac Price-to-Tangible-Book Historical Data

The historical data trend for Virbac's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => - [6] => - [7] => 5.51 [8] => 7.47 [9] => 5.91 )

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

5.51

7.47

5.91

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book																5.79	7.47	6.17	5.91	5.24

Competitive Comparison

For the Drug Manufacturers - General subindustry, Virbac's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virbac Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, Virbac's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Virbac's Price-to-Tangible-Book falls into.

Virbac Price-to-Tangible-Book Calculation

Virbac's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	354.75	/	76.319
	=	4.65

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Virbac Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Virbac's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.